About Pediatric Pharmaceuticals
Pediatric Pharmaceuticals, Inc. (PPI) was formed to develop and market unique pharmaceutical products designed to fulfill the needs of the medical community. Its first product CAFCIT, caffeine citrate for apnea of prematurity, received FDA approval in September 1999 and is now on the market throughout the U.S. nn PPI plans to target the development of pharmaceuticals, many of which will qualify as orphan drugs capable of obtaining the financial/patent benefits of the Orphan Drug Act. Major drug companies are usually not interested in these products because of their relatively small sales potential. The Company also feels that once certain specialty products are approved, they may find a larger audience through use in other indications. nnn As long term strategy, PPI plans to identify and financially support selected university and hospital research projects that offer strong potential as major pediatric and adult products. This investment program should provide the Company with a stream of new and innovative products as well as foster formal relationships with leading medical research centers.
Missing: Pediatric Pharmaceuticals's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Pediatric Pharmaceuticals's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Expert Collections containing Pediatric Pharmaceuticals
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Pediatric Pharmaceuticals is included in 1 Expert Collection, including Medical Devices.
Companies that have been granted at least 1 510(k) by the FDA since 2014. Companies tagged as #FDA510(K)
Pediatric Pharmaceuticals Frequently Asked Questions (FAQ)
Where is Pediatric Pharmaceuticals's headquarters?
Pediatric Pharmaceuticals's headquarters is located at 120 Wood Ave., Iselin.
What is Pediatric Pharmaceuticals's latest funding round?
Pediatric Pharmaceuticals's latest funding round is Other Investors.
Who are the investors of Pediatric Pharmaceuticals?
Investors of Pediatric Pharmaceuticals include Rho Ventures.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.